標(biāo)題: Titlebook: When Do I Take Which Distribution?; A Statistical Basis Uwe Wehrspohn,Dietmar Ernst Book 2022 The Author(s), under exclusive license to Sp [打印本頁(yè)] 作者: 神像之光環(huán) 時(shí)間: 2025-3-21 16:48
書(shū)目名稱When Do I Take Which Distribution?影響因子(影響力)
書(shū)目名稱When Do I Take Which Distribution?影響因子(影響力)學(xué)科排名
書(shū)目名稱When Do I Take Which Distribution?網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱When Do I Take Which Distribution?網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱When Do I Take Which Distribution?被引頻次
書(shū)目名稱When Do I Take Which Distribution?被引頻次學(xué)科排名
書(shū)目名稱When Do I Take Which Distribution?年度引用
書(shū)目名稱When Do I Take Which Distribution?年度引用學(xué)科排名
書(shū)目名稱When Do I Take Which Distribution?讀者反饋
書(shū)目名稱When Do I Take Which Distribution?讀者反饋學(xué)科排名
作者: Eosinophils 時(shí)間: 2025-3-21 23:16 作者: Cardiac 時(shí)間: 2025-3-22 03:12
ation where our actions affect those far away in time and space. Pesticides may affect non-target organisms many years after their original application; radiation and toxic chemicals may spread far from their source; apparently non-toxic compounds like PCBs and CFCs cause unexpected damage to unrela作者: 易于出錯(cuò) 時(shí)間: 2025-3-22 07:02 作者: 泰然自若 時(shí)間: 2025-3-22 10:22
Uwe Wehrspohn,Dietmar Ernst are retrieved from a whole organism and assayed. Exploitation of automation technology has made whole mount . hybridization a procedure that is amiable to high-throughput genomic studies. Combining automation with computer-aided image analysis makes this an efficient strategy for quantifying subtle作者: 完成才會(huì)征服 時(shí)間: 2025-3-22 16:51
2191-5482 ent in companies.Discusses German revision standards such asThis book provides the statistical basis for quantitative risk management by presenting and explaining the most important distributions. Distributions describe the occurrence and impact of a risk. They are a prerequisite for risk aggregatio作者: 失望未來(lái) 時(shí)間: 2025-3-22 19:12 作者: Graphite 時(shí)間: 2025-3-22 22:39
Distributions for the Effects of Risk,that each occurrence causes an individual loss. Thus, if a risk occurs more than once, the total loss is the sum of the individual losses. The basic forms of distributions for individual losses include points, closed bands, open bands and distributions that combine several forms. The sum of individu作者: Hangar 時(shí)間: 2025-3-23 04:56
Application of Distributions in ERM,n and adds an evaluation can be found on the Risk Kit toolbar under “Examples—Case Studies.” The model is presented in detail in a . Small and medium-sized companies will already be able to cover the requirements of PS 340 with this model.?Large companies, whose risk management process includes many作者: 豐滿中國(guó) 時(shí)間: 2025-3-23 05:57 作者: TIA742 時(shí)間: 2025-3-23 09:52 作者: amputation 時(shí)間: 2025-3-23 15:31
Distributions for the Effects of Risk,orms of distributions for individual losses include points, closed bands, open bands and distributions that combine several forms. The sum of individual losses combines a distribution for the frequency of occurrence of a risk with the distribution for the form of the individual occurrence.作者: 反感 時(shí)間: 2025-3-23 20:28
SpringerBriefs in Businesshttp://image.papertrans.cn/w/image/1027872.jpg作者: municipality 時(shí)間: 2025-3-23 23:45
https://doi.org/10.1007/978-3-031-07330-4Bernoulli Distribution; Poisson Distribution; Constant Distribution; Uniform Distribution; PERT; Trapezoi作者: 休閑 時(shí)間: 2025-3-24 02:48 作者: PRO 時(shí)間: 2025-3-24 07:49 作者: 外星人 時(shí)間: 2025-3-24 11:02 作者: 黃油沒(méi)有 時(shí)間: 2025-3-24 17:06 作者: 開(kāi)頭 時(shí)間: 2025-3-24 20:21 作者: Curmudgeon 時(shí)間: 2025-3-25 02:43 作者: 整理 時(shí)間: 2025-3-25 06:50 作者: 脆弱么 時(shí)間: 2025-3-25 09:46
Enhancing Cardiomyocyte Transcription Using In Vivo CRISPR/Cas9 Systemsral tissue environment. Modified CRISPR/Cas9 systems were developed to be used as guide (g) RNA programmable transcriptional activation platforms (CRISPRa) in vitro and in vivo allowing targeted or multiplexed gene activation studies. We specifically developed these tools to be applied in cardiomyoc作者: Stricture 時(shí)間: 2025-3-25 14:35 作者: Resection 時(shí)間: 2025-3-25 19:12
An Introduction to PEAR and Pyrushe messiness of specific context, turning it into a tool that can be used again and again. To come at this from another angle, if programmers love the reusable, they hate duplication. By creating libraries that can be reapplied, programmers avoid the need to implement similar solutions across multip作者: chuckle 時(shí)間: 2025-3-25 19:58 作者: resistant 時(shí)間: 2025-3-26 03:54
Einleitung,ngesichts der fortschreitenden Globalisierung auf kleine und mittlere Unternehmen (KMU) haben wird. Obwohl gro?e multinationale Unternehmen mit Tochterunternehmen in verschiedenen Teilen der Erde imMittelpunkt des Prozesses stehen, k?nnen sich auch deutscheMittelst?ndler nicht von den Folgen der Glo作者: 最初 時(shí)間: 2025-3-26 07:39
Coevolutionary life-time learning, allows for an elegant incorporation of life-time learning (LTL) within CGAs. This way, not only the genetic search but also the LTL component focuses on “not yet solved” problems. The performance of the new algorithm is compared with various other algorithms.作者: MAZE 時(shí)間: 2025-3-26 12:27 作者: 貴族 時(shí)間: 2025-3-26 14:55 作者: 惹人反感 時(shí)間: 2025-3-26 17:36 作者: 字形刻痕 時(shí)間: 2025-3-27 00:06 作者: Extemporize 時(shí)間: 2025-3-27 01:57
Functional Analysis of ESCRT-Positive Extracellular Vesicles in the , Wing Imaginal Disc,T and Hh-positive EVs in the lumenal space of both living and fixed wing imaginal discs. (3) The receptor-mediated capture of Hh-containing EVs on the surface of Hh-receiving cells. (4) The effect of manipulations of ESCRT function on the extracellular pool of Hh ligands.作者: 欲望小妹 時(shí)間: 2025-3-27 07:36 作者: indifferent 時(shí)間: 2025-3-27 09:40
The Group Logarithm Past and Present,er its use both in the theory of class groups of group rings and in the Galois structure of rings of algebraic integers. We conclude with a brief insight into its recent use in the construction of an adelic second Chern class for a non-commutative Riemann Roch theorem. The use of the group logarithm作者: 拱形大橋 時(shí)間: 2025-3-27 16:21
Biomarker Sample Collection and Handling in the Clinical Setting to Support Early-Phase Drug Develothe clinic of targeted therapeutics. This unprecedented opportunity to perform measures of human physiology responding to pharmacologic intervention requires an understanding of sample collection, handling (preanalytical variables), and assay qualification for the results to be informative and allow
